作者：阿飞 在2025年全球的IPO市场中，港交所是绝对的"王者"。 今年港股的IPO有多火？根据Wind资讯的统计数据，截至12月18日，港股市场年内共有102家企业完成上市，抛开周末、节假日等非交易日，几乎每两天就 有一只新股完成发行。 至此，2025年港交所IPO募资总额已达2700.86亿港元，时隔4年重回2000亿港元大关，预计全年募资额将超过2800亿港元。 而这一数字也让港交所以绝对优势登顶全球证券交易所募资榜首，远超纽约证券交易所的205亿美元（约合1600亿港元）。全球十大IPO项目中港交所独占4 席，成为全球大型新股的集聚地。 锣声密集到"不够用"，投行人士忙得"没有休息日"，连港交所行政总裁都笑称在海外路演时"饭都吃不上一口"，而这已成为今年港股IPO市场的常态。 政策技术双轮驱动 港股IPO强势回归 香港本地监管层面也在积极优化上市环境。今年5月，香港证监会与港交所联合推出"科企专线"，为特专科技公司及生物科技公司提供保密递交上市申请和 一对一咨询服务。 港股上市审批流程同步优化，监管评估周期缩短至30个工作日内，显著提升了上市效率。 从行业结构来看，科技与企业成为驱动港股IPO市场的 ...

中新社香港12月10日电 (记者 魏华都) 毕马威10日在香港发布《中国内地与香港IPO市场2025年回 顾与2026年展望》报告，预计2025年香港首次公开招股(IPO)集资额达2721亿港元，按年上升210%，位 居全球第一。 毕马威中国香港资本市场组主管合伙人刘大昌表示，越来越多高科技及生物科技企业选择来港上 市，凸显出本地支持政策及健全监管环境的吸引力。随着政策持续推动创新及新经济领域的发展，除 了"A+H"上市的持续势头外，预料2026年将是高科技企业上市的关键一年。 责任编辑：杨喜亭 报告指出，香港今年至今已完成17宗"A+H"上市，为历来最多，集资额占全年的一半，进一步印证 香港作为连接中国内地与国际资本市场桥梁的独特优势。同时，香港完成14宗未盈利生物科技公司上 市，较去年的4宗大幅增加；另有3宗特专科技公司上市，与去年持平。 截至今年12月7日，香港IPO市场录得316宗上市申请，较2024年底激增267%，当中92宗为"A+H"上 市申请。毕马威预测，如果计及已公开表示有意来港上市的A股企业，"A+H"上市申请预计将于短期内 突破100宗，为2026年带来良好开局。毕马威预料2026年香港 ...

香港证监会及港交所联合致函部分保荐人 对IPO申请质量表示担忧 12月9日，据彭博社报道，香港证监会与香港交易所的官员联名致函IPO保荐人，指出近期新上市申请数量激增背景下，部分投行提交的材料存在内 容不全、质量低下等问题，引发监管层对合规风险的担忧。 这封日期为12月5日的联名信指出，2025年香港IPO申请显著增加，部分保荐机构在应对高负荷业务时，暴露出对本地上市规则不熟悉、缺乏实操经 验等问题，导致申报文件不符合基本监管要求。 据悉，信函提及的不合标准的情况可能包括： 所提供的上市文件品质差劣，审查不足，如涉及业务模式的描述不够清晰、过度使用宣传用语； 选择性呈现行业数据以夸大上市申请人的市场地位； 保荐人未能及时回应监管机构的意见，哪怕已给予明确的指示，仍有保荐人对个案的基本事实都缺乏认知； 保荐人在招股阶段未能按既定时间表遵守相关的流程，甚至曾出现个案在处理一些关键监管流程（如审查配售的承配人以发布配发结果）时投行的负 责代表未能及时联络、或被指派的人不具备足够知识处理，导致未能满足招股阶段所规定的时间表等。 香港证监会的一位发言人表示，其与香港交易所向多家IPO保荐人发出了一封联合信函。香港交易所 ...

Group 1 - The core viewpoint of the articles highlights the resurgence of the Hong Kong capital market, driven by increased participation from international investors and a strong performance in IPO financing, particularly in the technology sector [1][2] - Hong Kong's IPO financing has ranked first globally this year, with a total refinancing amount reaching 456.1 billion HKD, more than double the new stock market fundraising amount during the same period [1] - The "Science and Technology Enterprise Special Line" policy introduced in May has significantly improved the efficiency of technology and biotech companies preparing for listing in Hong Kong, with nearly half of the submitted applications coming from tech firms [2] Group 2 - The total trading volume of collective investment schemes has reached a historical high, with sales surging by 76% to 2.24 trillion HKD, indicating strong demand for low-risk and stable-return investment options amid macroeconomic uncertainties [2] - Hong Kong has established itself as Asia's leading international bond issuance hub and the largest offshore RMB center, enhancing its attractiveness to bond issuers and global investors [2] - Hong Kong's strategic positioning as a "super connector" and "super value creator" allows it to facilitate cooperation between Chinese and international standards, particularly in emerging fields like data cross-border flow and artificial intelligence ethics [3]

Core Insights - The article highlights the surge of AI companies seeking to list in Hong Kong, driven by the rapid development of AI technology and its integration across various sectors [3][4][5]. Group 1: Listing Trends - As of September 30, 2025, Hong Kong has received a total of 380 listing applications, including 285 new applications and 94 pending from previous years [4]. - Among the 214 companies that have submitted listing applications but are not yet listed, 48 are in the AI sector, representing 22.43% of the total [4]. - Five AI companies have successfully listed in Hong Kong in 2025, covering various high-growth areas such as warehouse fulfillment, AI solutions, and digital therapy [5]. Group 2: Regulatory Environment - The implementation of the 18C listing rules in 2023 has significantly lowered the profitability and revenue thresholds for specialized technology companies, facilitating a smoother listing process for AI firms [13][15]. - The Hong Kong Stock Exchange has introduced the "Science and Technology Enterprise Express" to allow confidential submission of listing applications, reducing the risk of early disclosure of sensitive information [15]. Group 3: Market Dynamics - The tightening of IPO regulations in the A-share market has led to a noticeable trend of companies abandoning A-share listings in favor of Hong Kong, reflecting the more accommodating regulatory environment in Hong Kong [19][18]. - The number of companies waiting for IPO approval in the A-share market has decreased by 54.4% from September 30, 2023, to September 30, 2025, indicating a shift in market dynamics [18]. Group 4: Future Outlook - With the ongoing influx of AI companies into the Hong Kong market, it is expected that Hong Kong will further solidify its position as a hub for technology and innovation listings in Asia, providing ample investment opportunities for stakeholders [5][19].

Core Viewpoint - Cheng Tai Technology is seeking to go public in Hong Kong, with over 90% of its revenue derived from BYD, and has reported net losses for three consecutive years [7]. Group 1: Financial Performance - Cheng Tai Technology's revenue from BYD increased from 81.9% in 2022 to 93.6% in 2024 [7]. Group 2: IPO Process - The company submitted its prospectus to the Hong Kong Stock Exchange on June 23, aiming for an IPO under the "Special Technology Company" category, with Guotai Junan International as the sole sponsor [7]. Group 3: Legal and Compliance Issues - The company has received feedback from the regulatory authority regarding its historical capital contributions, share transfers, and compliance with legal standards [1][6]. - There are inquiries about the pricing rationale for share transfers and the legality of employee stock ownership plans [2][3].

Group 1: IPO Activity and Market Performance - Hong Kong's IPO activity and securities market performance have shown robust growth, reinforcing its position as a leading international financial center [1] - In the first seven months of the year, Hong Kong recorded 51 IPOs, with fundraising amounting to HKD 128 billion, a year-on-year increase of over 610% [1] - As of the end of July, there were over 220 IPO applications under review [1] - The average daily trading volume in the market surged by 85% to HKD 243.7 billion during the first seven months [1] Group 2: Asset and Wealth Management Growth - The number of license applications received by the Hong Kong Securities and Futures Commission (SFC) increased by 16% year-on-year, indicating a thriving market [2] - The asset and wealth management sector saw a strong growth, with assets under management for funds registered in Hong Kong increasing by 39% year-on-year [2] - The number of open-ended fund companies rose by 56% year-on-year, and the average daily trading volume of ETFs surged by 135.5% during the quarter [2] Group 3: Virtual Assets Development - The number of approved virtual asset spot ETFs in Hong Kong increased from six to nine, with three new virtual asset spot ETFs approved for staking activities [3] - As of the end of July, the number of licensed virtual asset trading platforms rose to 11, with 57 licensed entities permitted to provide virtual asset trading services [3] - The SFC is collaborating with the Financial Services and the Treasury Bureau to propose legislation for regulating virtual asset traders and custodians [3] Group 4: Investor Protection and Market Integrity - The SFC continues to prioritize investor protection, issuing warnings against market speculation related to stablecoins [3] - The SFC provided guidance to licensed institutions on preventing fraud and unauthorized trading, responding to international calls to combat scams [3] - A joint operation with the Independent Commission Against Corruption led to the arrest of two former executives of a listed company suspected of market manipulation through corrupt means [3]

Group 1 - Basic Semiconductor Co., Ltd. (BASiC Semiconductor) from Shenzhen submitted its IPO prospectus to the Hong Kong Stock Exchange on May 27, 2025, aiming for a public listing [1][2] - The China Securities Regulatory Commission (CSRC) issued supplementary material requirements from August 8 to August 14, 2025, requesting clarifications on various aspects of the company [1] - The CSRC's inquiries include the inconsistency in the identification of the controlling shareholder, the progress of state-owned shareholder identification, and the reasonableness of the share price for new shareholders in the past 12 months [1] Group 2 - The company is required to provide a conclusive legal opinion regarding the compliance of its establishment and past equity changes, as well as the background and fairness of its equity incentive plan [1] - The listing plan must detail the number of shares to be issued, the proportion of total share capital post-issuance, and the expected amount of funds to be raised, along with a comparison of the shareholding structure before and after "full circulation" [1] - The company must clarify whether the shares held by shareholders participating in the "full circulation" are subject to any pledges, freezes, or other rights defects [1]

Core Viewpoint - The article discusses the potential investment opportunities in various ETFs, particularly focusing on technology, robotics, chips, and infrastructure sectors, driven by favorable market conditions and government policies [3][4][10][12]. Group 1: Technology Sector - The Hang Seng Technology ETF (513010.SH) is highlighted, with a projected net inflow of HKD 731.2 billion from southbound funds in the first half of 2025, which is 91% of last year's total net purchases [3]. - The Hang Seng Technology Index has a PE-TTM of 21.19 as of August 4, 2025, indicating a valuation at the 15.86% percentile of its historical range, suggesting a favorable investment opportunity [4]. Group 2: Robotics Sector - The Robotics ETF (562500.SH) is positioned to benefit from government initiatives to develop intelligent robotics and new manufacturing equipment, with policies aimed at enhancing financing support for strategic sectors [6][7]. - The World Artificial Intelligence Conference showcased over 60 humanoid robots, indicating significant innovation and potential for commercialization in the robotics field [6]. Group 3: Chip Sector - The Chip ETF (159995.SZ) is influenced by the recent approval of H20 chip exports to China, signaling a temporary easing of U.S. export restrictions, although long-term challenges remain due to ongoing technology sanctions [9][10]. - The establishment of the National Integrated Circuit Industry Investment Fund with a registered capital of CNY 344 billion aims to bolster domestic chip manufacturing and reduce reliance on foreign technology [10]. Group 4: Infrastructure Sector - The Infrastructure ETF (516950.SH) is set to benefit from the government's plan to issue CNY 1.3 trillion in special bonds and CNY 4.4 trillion in project financing, focusing on infrastructure and equipment upgrades [11]. - The commencement of the Yaxia Hydropower Station project, with a total investment of CNY 1.2 trillion, is expected to drive demand across the entire infrastructure supply chain [11].

Core Viewpoint - The launch of the "Tech Company Fast Track" by the Hong Kong Stock Exchange has received positive market feedback, indicating a sustained interest in technology company listings, particularly following the recent listing of CATL [1] Group 1: Introduction of "Tech Company Fast Track" - The "Tech Company Fast Track" was officially launched on May 6, aimed at facilitating the listing applications of specialized technology and biotechnology companies [1] - Companies can submit their listing applications confidentially, which is particularly beneficial for those in early development stages or with non-commercialized products [1] Group 2: Listing Guidelines and Support - The Hong Kong Stock Exchange has updated its "New Listing Applicant Guide" to clarify that specialized technology and biotechnology companies can meet the requirements for innovative industries under the Main Board Listing Rules [1] - A professional team with relevant experience will lead the "Tech Company Fast Track," providing guidance on listing qualifications and suitability, including core product requirements and regulatory considerations [2]